Morning Alert: Amicus Therapeutics (NASDAQ:FOLD), EMC (NYSE:EMC), Rubicon Technology (NASDAQ:RBCN), Quest Rare Minerals Ltd. (NYSEMKT:QRM), Vera Bradley, Inc. (NASDAQ:VRA)
Amicus Therapeutics, Inc. (NASDAQ:FOLD) currently has a Zacks Rank #2 (Buy). Amicus Therapeutics, Inc. (NASDAQ:FOLD) belongs to Healthcare sector. Its weekly performance is 34.38%. On last trading day company shares ended up $7.27. Amicus Therapeutics, Inc. (NASDAQ:FOLD) distance from 50-day simple moving average (SMA50) is 76.12%. EMC (NYSE:EMC) declared a quarterly dividend on Friday, August 1st. Investors of record on Wednesday, October 1st will be given … Continue reading Morning Alert: Amicus Therapeutics (NASDAQ:FOLD), EMC (NYSE:EMC), Rubicon Technology (NASDAQ:RBCN), Quest Rare Minerals Ltd. (NYSEMKT:QRM), Vera Bradley, Inc. (NASDAQ:VRA)
Fast Moving Stocks: Chesapeake Energy (NYSE:CHK), Symantec (NASDAQ:SYMC), Altair Nanotechnologies, Inc. (NASDAQ:ALTI), Clean Energy Fuels Corp. (NASDAQ:CLNE), Vornado Realty Trust (NYSE:VNO)
On Aug. 21, 2014– Chesapeake Energy Corporation (NYSE:CHK) today announced that Brad Sylvester will join Chesapeake as Vice President – Investor Relations and Communications. Sylvester joins Chesapeake from Southwestern Energy Company. He will report to Chesapeake’s Chief Financial Officer, Nick Dell’Osso. Chesapeake Energy Corporation (NYSE:CHK) belongs to Basic Materials sector. Its net profit margin is 2.60% and weekly performance is 1.97%. On last trading day … Continue reading Fast Moving Stocks: Chesapeake Energy (NYSE:CHK), Symantec (NASDAQ:SYMC), Altair Nanotechnologies, Inc. (NASDAQ:ALTI), Clean Energy Fuels Corp. (NASDAQ:CLNE), Vornado Realty Trust (NYSE:VNO)
Active Biotech Stocks: Kite Pharma Drug
Kite Pharma, Inc (KITE) announced the publication of positive results from an ongoing phase I-IIa study on KTE-C19 in patients suffering from aggressive non-Hodgkin’s lymphoma in the Aug 25, 2014 issue of the American Society of Clinical Oncology’s Journal of Clinical Oncology. In the phase I-II study, KTE-C19 achieved 92% overall objective response rate. According to Kite Pharma, out of 13 patients with advanced B-cell … Continue reading Active Biotech Stocks: Kite Pharma Drug
Biotech Stocks: Amicus Therapeutics (FOLD) Soars High After Positive Results
Shares of Amicus Therapeutics (FOLD) soared 20.4% after the company announced positive data from its second phase III study (Study 012) on the oral small molecule chaperone migalastat HCl in Fabry patients with amenable mutations. The phase III study is evaluating the use of oral migalastat to standard-of-care enzyme replacement therapies (ERTs) − Sanofi’s (SNY) Fabrazyme and Shire’s (SHPG) Replagal − for Fabry disease. Eighteen-month … Continue reading Biotech Stocks: Amicus Therapeutics (FOLD) Soars High After Positive Results
Stock in Focus: Microsoft (NASDAQ MSFT) Offshore Cash
Microsoft Corp (NASDAQ MSFT) is currently sitting on almost $29.6 billion it would owe in US taxes if it repatriated the $92.9 billion of earnings it is keeping offshore, according to disclosures in the company’s most recent annual filings with the Securities and Exchange Commission. The amount of money that Microsoft is keeping offshore represents a significant spike from prior years, and the levies the … Continue reading Stock in Focus: Microsoft (NASDAQ MSFT) Offshore Cash
Stock in News: Google Buys Zync Reader
Google Inc (NASDAQ GOOG) announced that it has acquired special effects startup Zync Render, bringing the company that rendered the special effects for Looper, Star Trek Into Darkness and dozens of other feature films to its Cloud Platform and making its billing plan more flexible to avoid losing clients in the transition. Unlike previous cloud acquisitions, Google will require Zync clients to start using its … Continue reading Stock in News: Google Buys Zync Reader